DEAR MAYO CLINIC: I’ve heard that ovarian cancer is hard to detect. Can you tell me more about the symptoms and if there are any screenings? ANSWER: Ovarian cancer is relatively rare. However, it’s ...
DEAR MAYO CLINIC: I've heard that ovarian cancer is hard to detect. Can you tell me more about the symptoms and if there are any screenings? ANSWER: Ovarian cancer is relatively rare. However, it's ...
SurvivorNet on MSN
Newly approved ovarian cancer treatment combination with the drug Lifyorli helps give time after relapse
The FDA has approved Lifyorli (relacorilant) plus Abraxane for certain platinum‑resistant ovarian cancer patients, offering a ...
The FDA has granted Fast Track Designation to CTIM-76, a claudin-6 (CLDN6) x CD3 T cell engaging bispecific antibody, for the ...
Investigators compared mortality risk among long-term survivors of high-grade serous ovarian cancer versus the general US population to examine how mortality and recurrence trends have changed with ...
Researchers have uncovered an early survival response in ovarian cancer cells that may limit the effectiveness of widely used ...
Final analysis from the phase 2 OVATION 2 trial (NCT03393884) has demonstrated a continued and growing overall survival (OS) ...
Continuous treatment for stage 4 ovarian cancer highlights the importance of resilience and self-advocacy in patient care. Differentiating palliative care from hospice is crucial; palliative care ...
Morning Honey on MSN
Lori Gilman and Dr. Mitchel Hoffman AreTransforming the Fight Against Ovarian Cancer With H.O.W.
From different corners of the cancer journey, Lori Gilman and Dr. Mitchel Hoffman exemplify how modern medicine, genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results